Journal article icon

Journal article

Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients

Abstract:
Both phase-amplitude coupling (PAC) and beta-bursts in the subthalamic nucleus have been significantly linked to symptom severity in Parkinson's disease (PD) in humans and emerged independently as competing biomarkers for closed-loop deep brain stimulation (DBS). However, the underlying nature of subthalamic PAC is poorly understood and its relationship with transient beta burst-events has not been investigated. To address this, we studied macro- and micro electrode recordings of local field potentials (LFPs) and single unit activity from 15 hemispheres in 10 PD patients undergoing DBS surgery. PAC between beta phase and high frequency oscillation (HFO) amplitude was compared to single unit firing rates, spike triggered averages, power spectral densities, inter spike intervals and phase-spike locking, and was studied in periods of beta-bursting. We found a significant synchronisation of spiking to HFOs and correlation of mean firing rates with HFO-amplitude when the latter was coupled to beta phase (i.e. in the presence of PAC). In the presence of PAC, single unit power spectra displayed peaks in the beta and HFO frequency range and the HFO frequency was correlated with that in the LFP. Furthermore, inter spike interval frequencies peaked in the same frequencies for which PAC was observed. Finally, PAC significantly increased with beta burst-duration. Our findings offer new insight in the pathology of Parkinson's disease by providing evidence that subthalamic PAC reflects the locking of spiking activity to network beta oscillations and that this coupling progressively increases with beta-burst duration. These findings suggest that beta-bursts capture periods of increased subthalamic input/output synchronisation in the beta frequency range and have important implications for therapeutic closed-loop DBS.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/j.nbd.2019.02.005

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Clinical Neurosciences
Sub department:
BNDU
Role:
Author
ORCID:
0000-0002-8404-4742
More by this author
Role:
Author
ORCID:
0000-0003-0538-5109
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Clinical Neurosciences
Sub department:
BNDU
Role:
Author
ORCID:
0000-0002-1954-1873


More from this funder
Funding agency for:
Brown, P
Sharott, A
Grant:
MC_UU_12024/1
MC_UU_12024/1
More from this funder
Funding agency for:
Brown, P
Sharott, A
Grant:
MC_UU_12024/1
MC_UU_12024/1
More from this funder
Funding agency for:
Meidahl, A
More from this funder
Funding agency for:
Tinkhauser, G


Publisher:
Elsevier
Journal:
Neurobiology of Disease More from this journal
Volume:
127
Pages:
101-113
Publication date:
2019-02-10
Acceptance date:
2019-02-07
DOI:
EISSN:
1095-953X
ISSN:
0969-9961


Language:
English
Pubs id:
pubs:971993
UUID:
uuid:66733f72-18af-4c9d-848b-223bc961bcf2
Local pid:
pubs:971993
Source identifiers:
971993
Deposit date:
2019-02-13

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP